TFR Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Buy
10,871
+201
+2% +$46.8K 0.78% 36
2026
Q1
$2.61M Buy
10,670
+7,326
+219% +$1.71M 0.8% 31
2025
Q4
$692K Sell
3,344
-29
-0.9% -$5.74K 0.23% 89
2025
Q3
$625K Buy
3,373
+23
+0.7% +$3.94K 0.21% 95
2025
Q2
$512K Sell
3,350
-1,073
-24% -$165K 0.19% 103
2025
Q1
$734K Buy
4,423
+2,261
+105% +$354K 0.31% 78
2024
Q4
$313K Buy
+2,162
New +$335K 0.16% 85

Other funds holding JNJ

TFR Capital's JNJ Position: Q2 2026 in Review

TFR Capital increased its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, buying an estimated $46.8K and bringing the position to 10,871 shares worth $2.76M. The position accounts for 0.78% of the portfolio, ranked #36.

TFR Capital first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • TFR Capital held 10,871 shares of Johnson & Johnson worth $2.76M as of Q2 2026.
  • TFR Capital bought 201 Johnson & Johnson shares in Q2 2026, an estimated $46.8K.
  • Johnson & Johnson made up 0.78% of TFR Capital's portfolio in Q2 2026, its #36 holding.
  • TFR Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on TFR Capital's 13F filing for Q2 2026, filed 6 Aug 2026.